Inhibitors of cyclin-dependent kinases
US10894788B2 · kind B2 · utility
6Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2019 |
| Grant date | Jan 19, 2021 |
| Priority date | — |
| Expiry date | Jun 28, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are inhibitors of cyclin-dependent kinases (CDKs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.